Скачать или смотреть Bexagliflozin | Bexagliflozin, SGLT2 inhibitor for type 2 diabetes | Novel Drug

Bexagliflozin is novel sodium glucose co-transporter, SGLT2 inhibitor and is used in type 2 diabetes mellitus. it acts on renal tubules and inhibits glucose reabsorption and glucose is excreted from kidneys independently from insulin sensitivity.
Bexagliflozin a sodium-glucose co-transporter 2 (SGLT2) inhibitor, is proving to be a game-changer in treating diabetes among children. We'll explore its mechanism of action, which helps reduce blood glucose levels by inhibiting glucose reabsorption in the kidneys.
Moreover, we'll shed light on the broader impact of Bexagliflozin beyond glycemic control. Discover its potential benefits in reducing body weight, improving cardiovascular health, and addressing metabolic syndrome in pediatric patients.

#drabdulmalikofficial
#bexagliflozin
#PediatricDiabetes
#SGLT2Inhibitors
#InnovativeTherapies
#diabetescare
#GlycemicControl
#metabolicsyndrome
#cardiovascularhealth
#diabetes